I was a dr before the Affordable Care Act. And people w/ cancer did hit lifetime caps & had further treatment denied by insurers. They were dropped from plans, declared bankruptcy, & died. We are NEVER EVER going back to that. #PresidentialDebate2024 #MedTwitter

If a study was well-designed, a negative study is never a failed study. Studies that give us a definitive answer, whether or not it’s the answer we hoped for, & offer clues as to why our hypothesis was wrong are successes. #MedTwitter #OncTwitter #ESMO24

Jennifer Ligibel from Dana-Farber’s Breast Oncology Center discusses the eMOUVOIR and OptiTrain studies of exercise interventions for patients with early breast cancer #ESMO24 #ESMOAmbassadors

Here at #ESMO24 OncoAlert 🚨is proud to be involved in this great study in patients and physicians regarding attitudes and perspectives on requesting brain imaging screening in metastatic #BreastCancer ⭐️you can find it NOW AT POSTER SESSION 429P We Proudly present

#ESMO24! TREAT ctDNA trial, led by EORTC under BIG against Breast Cancer, compares elacestrant vs. standard ET in ER+/HER2- BC pts with #ctDNA relapse. Recruitment is ongoing and will reach 12 countries. Check 338 TiP poster presented by Michail ignatiadis HaDEA #EU4Health #bcsm ESMO - Eur. Oncology

Congratulations Stephen V Liu, MD ,Marina Garassino Benjamin Besse #ESMO2024 . Wonderfull presentation ADCs. Discussing a lot of aspects about these drugs. Activity, safety, toxicity. When and where use. This aspect still needs to be discussed!! Great discussion.

Dr. Nancy Lin (Nancy Lin, MD) provided a great overview of #CNS disease in today's special #ESMO24 symposium on the management of #oligoprogressive disease.

At #ESMO24, Gini Harrison EGFR Positive Lung Cancer UK Trustee brings to life the importance of open discussions between lung cancer care teams & patients on side effects & how to manage them. As Gini shares, patients can be fearful to report over concerns of being taken off their life saving drugs👇

You've heard of the nine circles of Hell? A patient with cancer documented the TWENTY-SIX steps necessary to get their medication (as an oncologist I know a vicious cycle when I see one)

We need more sensitive ways (than CT scans) to monitor for ADC-related ILD. Could liquid biopsy help? Check out our proof-of-concept study of ILD monitoring through lung-specific cfDNA, used as a surrogate for pulmonary damage. Led by Albert Grinshpun esmoopen.com/article/S2059-…

We should try this either as primary or secondary prevention for T-Dxd pneumonitis… Paolo Tarantino

I constantly see consults where Memantine was not offered with Whole Brain RT. Radiation friends, what is your practice? Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy ncbi.nlm.nih.gov/pmc/articles/P…

There is a rising incidence of early-onset (EO) cancers. Traditionally observed in adults over the age of 65, some solid tumors are now increasingly diagnosed in younger individuals under the age of 50 (annual percentage increase of 2.5% for pancreas, 5% for oropharynx, 8% for

Congrats to ⁦MD Anderson Cancer Center⁩ #IBC program members ⁦Bora Lim, MD⁩ ⁦Angela Alexander PhD⁩ ⁦⁦Naoto T Ueno, MD, PhD⁩ Dr. Nasrazadani for collaborations on Dr. Zhang’s ⁦BCMHouston⁩ work on tumor immunosuppression/myeloid–B cell interactions! nature.com/articles/s4155…

Imaging has limitations. ctDNA has limitations. Can the two together overcome the distinct limitations? Very excited about some upcoming data from several studies Daniel Stover, MD, FASCO is doing with Foundation Medicine and, separately Broad Institute!

My top list of phrases that are not really patient friendly. #ESMO24 ❌ Grade 5 Events 🤨 ❌ AEs being manageable/tolerable 🥱 ❌ How to manage patients 😬 ❌ Patients = Subjects 🙄 ❌ Not clinically meaningful 🤔 Anyone want to continue the list? OncoAlert

#OncTwitter & #bcsm, let’s support this amazing kid. He’s making the world better for families like his that have been affected by #cancer.